Dietary cosupplementation with vitamin E and coenzyme Q10 inhibits atherosclerosis in apolipoprotein E gene knockout mice

Arteriosclerosis, Thrombosis, and Vascular Biology

Volumn 21, Issue 4, 2001, Pages 585-593

  Thomas, Shane R ^a   Leichtweis, Steven B ^a   Pettersson, Knut ^b   Croft, Kevin D ^c   Mori, Trevor A ^c   Brown, Andrew J ^a   Stocker, Roland ^a  

^a HEART RESEARCH INSTITUTE   (Australia)

^b ASTRAZENECA R AND D   (Sweden)

^c UNIVERSITY OF WESTERN AUSTRALIA   (Australia)

Author keywords

Antioxidant; Atherogenesis; Oxidation; Ubiquinol; Ubiquinone; tocopherol

Indexed keywords

7 OXOCHOLESTEROL; ALPHA TOCOPHEROL; ANTIOXIDANT; APOLIPOPROTEIN E; CHOLESTEROL; LIPID HYDROPEROXIDE; LOW DENSITY LIPOPROTEIN; PEROXY RADICAL; UBIDECARENONE; UBIQUINONE;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ANTIOXIDANT ACTIVITY; AORTA ARCH; AORTA ROOT; ARTICLE; ATHEROGENESIS; ATHEROSCLEROSIS; CHOLESTEROL BLOOD LEVEL; CONTROLLED STUDY; DIET SUPPLEMENTATION; KNOCKOUT MOUSE; LIPID DIET; LIPID PEROXIDATION; MALE; NONHUMAN; OXIDATION; PRIORITY JOURNAL;

EID: 0035049630     PISSN: 10795642     EISSN: None     Source Type: Journal    
DOI: 10.1161/01.ATV.21.4.585     Document Type: Article

References (60)

1. Beyond cholesterol: Modifications of low-density lipoprotein that increase its atherogenicity
2. The role of oxidized lipoproteins in atherogenesis
3. Lipids and oxidised lipids in human atherosclerotic lesions at different stages of development
4. Human atherosclerotic plaque contains both oxidized lipids and relatively large amounts of α-tocopherol and ascorbate
5. Evidence for the presence of oxidatively modified low density lipoprotein in atherosclerotic lesions of rabbit and man
6. Scavenger receptor-independent stimulation of cholesterol esterification in macrophages by low density lipoprotein extracted from human aortic intima
7. Presence of hypochlorite-modified proteins in human atherosclerotic lesions
8. Reactive nitrogen intermediates promote low density lipoprotein oxidation in human atherosclerotic intima
9. Co-existence of oxidized lipids and α-tocopherol in all lipoprotein fractions isolated from advanced human atherosclerotic plaques
10. Separation and characterization of cholesteryl oxo- and hydroxy-linoleate in human atherosclerotic plaque
11. Oxysterols and atherosclerosis
12. 2-isoprostanes in human atherosclerotic lesions
13. 2-isoprostanes, are present in increased amounts in human atherosclerotic lesions
14. 2-isoprostanes) are formed in situ on phospholipids
15. Oxysterols present in atherosclerotic tissue decrease the expression of lipoprotein lipase messenger RNA in human monocyte-derived macrophages
16. 7-Hydroperoxycholesterol and its products in oxidized low density lipoprotein and human atherosclerotic plaque
17. Tocopherol-mediated peroxidation: The pro-oxidant effect of vitamin E on the radical-initiated oxidation of human low-density lipoprotein
18. Recognition of oxidized low density lipoprotein by the scavenger receptor of macrophages results from derivatization of apolipoprotein B by products of fatty acid peroxidation
19. 2α increases platelet adhesion and reduces the antiadhesive and antiaggregatory effects of NO
20. 2 receptors
21. Dietary and pharmacological antioxidants and atherosclerosis
22. Dissociation of atherogenesis from aortic accumulation of lipid hydro(per)oxides in Watanabe heritable hyperlipidemic rabbits
23. Antioxidants and atherosclerotic heart disease
24. Tocopherol-mediated peroxidation (TMP) of lipoproteins: Implications for vitamin E as a potential anti-atherogenic supplement
25. A role for reduced coenzyme Q in atherosclerosis?
26. The ambivalence of vitamin E in atherogenesis
27. Vitamin E suppresses isoprostane generation in vivo and reduces atherosclerosis in apoE-deficient mice
28. Antioxidant defenses in rat intestine and mesenteric lymph
29. 10 on experimental atherosclerosis and chemical composition and quality of atheroma in rabbits
30. 10 in apolipoprotein E gene knockout mice
31. Ubiquinol-10 protects human low density lipoprotein more efficiently against lipid peroxidation than does α-tocopherol
32. 10 results in increased levels of ubiquinol-10 within circulating lipoproteins and increased resistance of human low density lipoprotein to the initiation of lipid peroxidation
33. Cosupplementation with coenzyme Q prevents the pro-oxidant effect of α-tocopherol and increases the resistance of low-density lipoprotein towards transition metal-dependent oxidation initiation
34. Comparative antioxidant activity of tocotrienols and other natural lipid-soluble antioxidants in a homogeneous system, and in rat and human lipoproteins
35. Rapid isolation of lipoproteins and assessment of their peroxidation by HPLC postcolumn chemiluminescence
36. Simultaneous determination of tocopherols, ubiquinols, and ubiquinones in blood, plasma, tissue homogenates, and subcellular fractions
37. Changes to lipids and antioxidants in plasma and aortae of apoE-deficient mice
38. Site-specific anti-atherogenic effect of probucol in apolipoprotein E deficient mice
39. Assessment of pro- and anti-oxidant activity of vitamin E in human low density lipoprotein and plasma
40. Radical-induced lipoprotein and plasma lipid oxidation in normal and apolipoprotein E gene knockout (apoE-/-) mice. ApoE-/- mouse as a model for testing the role of tocopherol-mediated peroxidation in atherogenesis
41. Evaluation of an isoluminol chemiluminescence assay for the detection of hydroperoxides in human blood plasma
42. Sterol efflux is impaired from macrophage foam cells selectively enriched with 7-ketocholesterol
43. 2-isoprostanes using gas chromatography-mass spectrometry
44. Selective and sensitive measurement of vitamin C, ubiquinol-10, and other low molecular weight antioxidants
45. Paradoxical enhancement of atherosclerosis by probucol treatment in apolipoprotein E-deficient mice
46. α-Tocopherol supplementation of macrophages does not influence their ability to oxidize LDL
47. Macrophage enrichment with the isoflavan glabridin inhibits NADPH oxidase-induced cell-mediated oxidation of low density lipoprotein: A possible role for protein kinase C
48. Inhibition of cell proliferation by α-tocopherol: Role of protein kinase C
49. α-Tocopherol inhibits aggregation of human platelets by a protein kinase C-dependent mechanism
50. The effects of α-tocopherol supplementation on monocyte function: Decreased lipid oxidation, interleukin 1 beta secretion, and monocyte adhesion to endothelium
51. Vascular incorporation of α-tocopherol prevents endothelial dysfunction due to oxidized LDL by inhibiting protein kinase C stimulation
52. 10 protects coronary endothelial function from ischemia reperfusion injury via an antioxidant effect
53. Relation of vascular oxidative stress, α-tocopherol, and hypercholesterolemia to early atherosclerosis in hamsters
54. Dietary β-carotene and α-tocopherol combination does not inhibit atherogenesis in an apoE-deficient mouse model
55. Vitamin E supplementation and cardiovascular events in high-risk patients: The Heart Outcomes Prevention Evaluation Study Investigators
56. The antioxidant butylated hydroxytoluene protects against atherosclerosis
57. Low density lipoprotein is protected from oxidation and the progression of atherosclerosis is slowed in cholesterol-fed rabbits by the antioxidant N,N'-diphenyl-phenylenediamine
58. Antiatherogenic effects of the antioxidant BO-653 in three different animal models
59. A rapid and simple screening test for potential inhibitors of tocopherol-mediated peroxidation of LDL lipids
60. Do vitamin E supplements in diets for laboratory animals jeopardize findings in animal models of disease?